Oriahnn (elagolix, estradiol, and norethindrone acetate capsules; elagolix capsules)

Type: drug

Status: FDA Approved

Developer: AbbVie Inc.

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026